Documents
Assess controlled documents and supporting evidence, identify gaps or inconsistencies, and prepare proposed drafts, amendments and remediation actions for review.
Regulated work · human supervised
Dahlia is a human-supervised regulated-work platform being developed for small pharma, biotech, GxP and medtech teams. It uses an organisation's own context, controlled requirements, evidence and instructions to perform substantive recurring work for accountable human review.
Inside Dahlia, Ivy gathers and analyses evidence, applies structured reasoning and prepares draft outputs through defined workflows. Dahlia takes on more of the work around the decision, so qualified people can focus their time on delivery, judgement and approval rather than carrying out every step themselves.
The commercial case
Across regulated life sciences, work is performed across Operations, Quality, Manufacturing, Regulatory, Clinical Operations, Supply Chain, Engineering and other accountable functions. The burden often sits in the work around the decision: gathering evidence, interpreting controlled requirements, finding gaps, tracing what happened, structuring analysis and drafting the record.
DahliaIvy is preparing a founding-client service built around reserved monthly capacity across multiple agreed workflows. Dahlia takes on evidence gathering, structured analysis, reasoning and drafting, so qualified people can review and decide from a prepared evidence base rather than reconstructing the work themselves. It is additional operating capacity for the recurring work around regulated decisions, not a replacement for the people accountable for them.
How Dahlia works
The same controlled pattern can be applied across different regulated workflows, source frameworks and organisational contexts.
Capture services, people, systems, constraints and the context that changes what a workable answer looks like.
Work from controlled sources, organisational documents and the evidence relevant to the defined workflow.
Identify gaps, inconsistencies, dependencies and questions that require attention.
Develop traceable proposed findings, actions or remediation proportionate to the context.
Draft the assessment, record, document change or review package required by the workflow.
A qualified person reviews, changes, accepts or rejects the work and remains accountable for the decision.
Dahlia does not replace accountable human decisions. It prepares the regulated work around those decisions so qualified people can review and decide from a structured evidence base.
Initial workflow families
Dahlia uses defined workflows that draw on organisational context, controlled requirements, evidence and instructions. Each workflow is delivered within an agreed scope and prepared for review by the organisation’s accountable people.
Assess controlled documents and supporting evidence, identify gaps or inconsistencies, and prepare proposed drafts, amendments and remediation actions for review.
Gather the record, structure the investigation, analyse contributing information and prepare proposed actions, records and follow-up for accountable review.
Structure the proposed change, gather affected requirements and evidence, assess impacts and prepare the controlled review package.
Bring together the relevant context, requirements and evidence, structure the risk assessment and prepare a traceable draft for qualified human review. Final risk acceptance remains with the client.
Organise qualification evidence, identify missing or unsupported controls, and prepare risk-based review material for authorised human review and ongoing oversight.
Assemble and test the evidence trail, identify readiness gaps, prepare response material and help teams focus attention before review.
The work may be performed across Quality, Operations, Manufacturing, Regulatory, Clinical Operations, Supply Chain, Engineering or another regulated function. The organisation's designated qualified or accountable person reviews and decides; Quality may provide oversight or final approval where required.
Ongoing client capacity
The founding-client service is designed around reserved monthly operating capacity across multiple agreed workflows. Work can be submitted to the agreed secure workspace and queue at any time. This is reserved capacity, not an unlimited workload or a promise of 24/7 staffed response or instant turnaround. Workflows, priorities, capacity, delivery expectations, information handling and any permitted AI use are agreed before controlled client materials are accepted.
Agree the workflows, monthly capacity, priorities, delivery expectations, controls, acceptance criteria and accountable reviewers.
Work enters the agreed workspace and queue. Dahlia carries out the evidence review, analysis, structured reasoning and drafting. For founding clients, every output is reviewed before delivery by DahliaIvy's founder, bringing 15 years of experience to the review.
The client's qualified people review the work, request amendments, accept or reject outputs, and control final approval, controlled filing and implementation.
The client receives the agreed draft work product. Founder review is an additional quality step; it supplements rather than replaces the client's professional and quality review or final approval.
The client's QMS, eQMS, SharePoint environment or other approved repository remains the authoritative location for controlled records.
Monthly capacity, scope, fees, delivery responsibilities and engagement controls are agreed before work begins. See our Security & Trust approach for the intended founding-client workflow and qualification process.
Regulated life-sciences direction
Dahlia is being developed for small pharma, biotech, GxP and medtech teams whose qualified people carry recurring document, evidence and quality-system work. Each proposed workflow remains subject to defined scope, appropriate controls and accountable human review.
Defined work across documents, quality events, changes, risks, suppliers and inspection preparation, within an agreed engagement scope.
Recurring work where controlled requirements, evidence, traceability and authorised review shape operational decisions.
Cross-functional regulated work requiring structured evidence, documented reasoning and accountable human approval.
These are intended application environments. Availability and engagement controls are confirmed workflow by workflow; not every workflow is an automated production software module.
The AI inside Dahlia
Ivy is the AI inside Dahlia. Working within a defined workflow, Ivy uses the organisation’s context, controlled source material, evidence and instructions to gather information, identify what is missing, structure analysis and prepare draft work for review.
Ivy supports the work. It does not become the accountable decision-maker. Qualified people determine what is correct, what is appropriate and what is approved.
Ongoing regulated-work capacity
DahliaIvy is preparing an ongoing founding-client service: reserved monthly operating capacity across multiple agreed workflows.
Your team can submit work to the agreed workspace and queue at any time. Dahlia prepares the evidence review, analysis, structured reasoning and draft output, and every founding-client output receives founder technical review before delivery. The client's qualified people can request amendments and control final approval, controlled filing, implementation and use. Workflows, priorities, capacity and delivery expectations are agreed for the service; information handling and any permitted AI use are agreed before controlled materials are accepted.
About DahliaIvy
DahliaIvy was founded by Priscilla Thiyageas, a quality and operations leader with experience across regulated life sciences, supply chain and clinical-trial environments.
DahliaIvy is building Dahlia around a practical observation: regulated teams do not necessarily need another place to store work. They need more help getting substantive work done without weakening the controls or professional accountability their environments require. Ivy is the AI inside Dahlia and assists with evidence review, structured analysis and drafting; qualified people remain responsible for review, decisions and approval.
Direct correspondence: hello@dahliaivy.com
Start a conversation
Use this form for product and use-case conversations, investment or funding enquiries, partnerships, advisory discussions, accelerators, grants or anything else.
Prefer email? hello@dahliaivy.com
DahliaIvy